Clinical trial

Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

NCT05300958

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-03-21

PhasePHASE2

Study timeline

Study start (actual)2022-03-21Date precision: day

Registry last updated2025-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Interventions

Deferoxamine Plus ChemotherapyDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05300958 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.